CymaBay Therapeutics, Inc.
NASDAQ:CBAY
32.48 (USD) • At close March 21, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | 2015 Q3 | 2015 Q2 | 2015 Q1 | 2014 Q4 | 2014 Q3 | 2014 Q2 | 2014 Q1 | 2013 Q4 | 2013 Q3 | 2013 Q2 | 2013 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.057 | 0 | 31.016 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.207 | 0 | 0 | 4.793 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.056 | 0.215 | 0.211 | 0.199 | 0.185 | 0.182 | 0.174 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0.001 | -0.215 | 30.805 | -0.199 | -0.185 | -0.182 | -0.174 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.207 | 0 | 0 | 4.793 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.018 | 0 | 0.993 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 22.693 | 19.962 | 19.537 | 18.551 | 16.23 | 15.459 | 17.891 | 18.415 | 18.405 | 17.01 | 16.745 | 12.382 | 10.688 | 7.743 | 7.942 | 9.509 | 20.937 | 23.193 | 21.119 | 18.588 | 16.397 | 17.853 | 14.397 | 9.477 | 6.669 | 4.184 | 4.044 | 4.041 | 3.848 | 3.534 | 4.131 | 4.428 | 4.051 | 4.528 | 4.26 | 4.187 | 5.277 | 3.848 | 4.083 | 2.615 | 1.363 | 0.703 | 0.969 | 1.49 |
| General & Administrative Expenses
| 19.806 | 12.245 | 11.578 | 8.324 | 7.247 | 5.904 | 5.878 | 6.087 | 6.104 | 5.179 | 6.521 | 5.236 | 5.186 | 4.494 | 3.398 | 4.347 | 4.532 | 4.514 | 4.529 | 5.663 | 4.158 | 3.276 | 3.574 | 3.373 | 2.894 | 2.21 | 3.582 | 3.701 | 2.839 | 2.13 | 2.215 | 2.461 | 1.796 | 2.201 | 2.285 | 2.589 | 2.332 | 1.687 | 1.666 | 2.5 | 2.091 | 0.683 | 1.172 | 0.925 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 19.806 | 12.245 | 11.578 | 8.324 | 7.247 | 5.904 | 5.878 | 6.087 | 6.104 | 5.179 | 6.521 | 5.236 | 5.186 | 4.494 | 3.398 | 4.347 | 4.532 | 4.514 | 4.529 | 5.663 | 4.158 | 3.276 | 3.574 | 3.373 | 2.894 | 2.21 | 3.582 | 3.701 | 2.839 | 2.13 | 2.215 | 2.461 | 1.796 | 2.201 | 2.285 | 2.589 | 2.332 | 1.687 | 1.666 | 2.5 | 2.091 | 0.683 | 1.172 | 0.925 |
| Other Expenses
| -0.003 | -0.002 | 1.282 | 0.487 | 0 | 0 | 0.002 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.071 | 5.075 | 0 | 0 | 0 | 0 | 1.453 | -0.086 | -4.655 | -0.777 | -1.798 | -1.064 | -2.134 | 0.033 | 0.081 | -0.358 | 0.32 | 0.136 | 1.083 | 5.327 | 4.575 | -4.949 | -0.254 | 2.749 | -4.775 | -0.287 | 0.298 | 0.126 | -0.002 |
| Operating Expenses
| 42.499 | 32.207 | 31.115 | 26.875 | 23.477 | 21.363 | 23.769 | 24.502 | 24.509 | 22.189 | 23.266 | 17.618 | 15.874 | 12.237 | 11.34 | 13.856 | 25.469 | 27.707 | 25.648 | 24.251 | 20.555 | 21.129 | 17.971 | 12.85 | 9.563 | 6.394 | 7.626 | 7.742 | 6.687 | 5.664 | 6.346 | 6.889 | 5.847 | 6.729 | 6.545 | 6.776 | 7.609 | 5.535 | 5.749 | 5.115 | 3.454 | 1.386 | 2.141 | 2.415 |
| Operating Income
| -42.498 | -32.207 | -0.099 | -26.875 | -23.477 | -21.363 | -23.769 | -24.502 | -24.509 | -22.189 | -23.266 | -17.618 | -15.873 | -11.65 | -11.152 | -13.927 | -30.544 | -27.707 | -25.648 | -24.251 | -20.555 | -21.129 | -17.971 | -12.85 | -4.356 | -6.394 | -7.626 | -2.949 | -6.687 | -5.664 | -6.346 | -6.889 | -5.847 | -6.729 | -6.545 | -6.776 | -7.609 | -5.535 | -5.749 | -5.115 | -3.454 | -1.386 | -2.141 | -2.415 |
| Operating Income Ratio
| -745.579 | 0 | -0.003 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.837 | 0 | 0 | -0.615 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.596 | -1.675 | 1.282 | -1.903 | -3.156 | -3.142 | -3.325 | -3.267 | -2.034 | -0.493 | 0.044 | 0.067 | 0.001 | 0.587 | 0.188 | -0.071 | -5.075 | 1.425 | 1.61 | 1.176 | 1.106 | 1.453 | -0.493 | -4.655 | -0.777 | -1.798 | -1.064 | -2.134 | 0.033 | 0.081 | -0.358 | 0.32 | 0.136 | 1.083 | 5.327 | 4.575 | -4.949 | -0.254 | 2.749 | -4.775 | -0.287 | 0.298 | 0.126 | -0.002 |
| Income Before Tax
| -41.902 | -33.882 | -0.808 | -28.778 | -26.633 | -24.505 | -27.094 | -27.769 | -26.543 | -22.682 | -23.222 | -17.551 | -15.751 | -11.421 | -10.726 | -13.088 | -29.413 | -26.282 | -24.038 | -23.075 | -19.449 | -18.563 | -17.531 | -17.005 | -5.043 | -8.234 | -8.929 | -5.351 | -6.952 | -5.879 | -6.992 | -6.848 | -5.979 | -5.865 | -1.357 | -2.328 | -12.722 | -5.961 | -3.172 | -10.062 | -3.914 | -1.307 | -2.223 | -2.628 |
| Income Before Tax Ratio
| -735.123 | 0 | -0.026 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.969 | 0 | 0 | -1.116 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | -0.215 | 5.9 | 6.306 | 9.748 | 3.142 | 3.325 | 3.267 | 5.139 | 0.029 | 0 | 0 | -0.123 | -0.816 | -0.614 | -0.768 | -0.15 | 1.425 | 1.61 | 1.176 | 1.106 | 1.453 | 0.042 | -4.447 | -0.543 | -1.54 | -0.781 | -1.829 | 0.361 | 0.422 | -0.022 | 0.652 | 0.465 | 1.348 | 5.492 | 4.729 | -4.759 | -0.063 | 2.938 | -4.591 | -0.105 | 0.517 | 0.335 | 0.21 |
| Net Income
| -41.902 | -33.882 | -0.808 | -35.084 | -36.381 | -27.647 | -30.419 | -31.036 | -26.543 | -22.682 | -23.222 | -17.551 | -15.751 | -11.421 | -10.726 | -13.088 | -29.413 | -26.282 | -24.038 | -23.075 | -19.449 | -18.563 | -17.531 | -17.005 | -5.043 | -8.234 | -8.929 | -5.351 | -6.952 | -5.879 | -6.992 | -6.848 | -5.979 | -5.865 | -1.357 | -2.328 | -12.722 | -5.961 | -3.172 | -10.062 | -3.914 | -1.307 | -2.223 | -2.628 |
| Net Income Ratio
| -735.123 | 0 | -0.026 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.969 | 0 | 0 | -1.116 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.37 | -0.32 | -0.008 | -0.36 | -0.41 | -0.33 | -0.36 | -0.36 | -0.38 | -0.33 | -0.34 | -0.25 | -0.23 | -0.17 | -0.16 | -0.19 | -0.43 | -0.38 | -0.35 | -0.37 | -0.31 | -0.31 | -0.3 | -0.32 | -0.094 | -0.21 | -0.31 | -0.2 | -0.26 | -0.25 | -0.3 | -0.29 | -0.26 | -0.27 | -0.089 | -0.15 | -0.84 | -0.44 | -0.32 | -1.02 | -0.4 | -0.093 | -0.16 | -0.19 |
| EPS Diluted
| -0.37 | -0.32 | -0.008 | -0.36 | -0.41 | -0.31 | -0.35 | -0.35 | -0.38 | -0.33 | -0.34 | -0.25 | -0.23 | -0.17 | -0.16 | -0.19 | -0.43 | -0.38 | -0.35 | -0.37 | -0.31 | -0.31 | -0.3 | -0.32 | -0.094 | -0.21 | -0.31 | -0.2 | -0.26 | -0.25 | -0.3 | -0.29 | -0.26 | -0.27 | -0.089 | -0.15 | -0.84 | -0.44 | -0.3 | -1.02 | -0.4 | -0.093 | -0.16 | -0.19 |
| EBITDA
| -42.442 | -32.207 | 4.021 | -24.176 | -22.558 | -20.504 | -23.272 | -24.235 | -24.309 | -21.984 | -23.091 | -17.454 | -15.711 | -12.665 | -11.372 | -13.632 | -24.338 | -26.138 | -23.898 | -22.937 | -19.383 | -18.549 | -16.983 | -16.785 | -4.8 | -7.968 | -8.637 | -5.037 | -6.616 | -5.528 | -6.65 | -6.511 | -5.645 | -5.594 | -1.187 | -2.168 | -12.527 | -5.765 | -2.978 | -9.875 | -3.727 | -1.079 | -1.999 | -2.39 |
| EBITDA Ratio
| -744.596 | 0 | 0.13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.922 | 0 | 0 | -1.051 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |